Skip to main content
    M

    Merit Medical Systems Inc (MMSI)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $86.35
    -0.28 (-0.32%)

    Market Cap: $5.19B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Merit Medical Systems Inc (MMSI) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Merit Medical Systems (MMSI) to earn $4.35 per share in the fiscal year ending Dec 31, 2026, on revenue of $1.64B. Of 12 analysts, 9 rate the stock Buy or Strong Buy, 3 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 7 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 12 ratings average 1.83, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 75% of the ratings.

    RatingAnalystsShare
    Strong Buy541.7%
    Buy433.3%
    Hold325.0%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    12

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 7.4% and revenue estimates rise 6.1%.

    Fiscal year ending Dec 31, 2026
    $4.35
    EPS consensus, revenue $1.64B
    Fiscal year ending Dec 31, 2027
    $4.67
    EPS consensus, revenue $1.74B
    Next report
    Feb 22, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$4.35$4.34 to $4.3711$1.64B$1.64B to $1.64B12
    Dec 31, 2027$4.67$4.51 to $4.8211$1.74B$1.72B to $1.76B12

    Quarterly Estimates

    The EPS consensus falls from $1.13 for the quarter ending Dec 31, 2026 to $1.02 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$1.13$1.07 to $1.1914$430.84M$412.76M to $446.15M14
    Mar 31, 2027$1.02$0.99 to $1.059$408.89M$402.87M to $414.10M8

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 16 upward and 2 downward EPS revisions. Raises outnumber cuts in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202670
    Fiscal year ending Dec 31, 202761
    Quarter ending Mar 31, 202731

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 1.2% from $4.30.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$4.35$4.35$4.30$4.30$4.30+1.2%
    Fiscal year ending Dec 31, 2027$4.67$4.67$4.61$4.61$4.61+1.3%
    Quarter ending Mar 31, 2027$1.02$1.02$1.02$1.02$1.01+1.1%

    Frequently Asked Questions About MMSI

    What is the MMSI stock forecast?

    Consensus analyst estimates put Merit Medical Systems's EPS at $4.35 for the fiscal year ending Dec 31, 2026, on revenue of $1.64B. The consensus rating from 12 analysts is Buy.

    How do analysts rate MMSI stock?

    Of 12 analysts covering Merit Medical Systems, 5 rate it Strong Buy, 4 Buy, 3 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from MMSI next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $4.35, with estimates from $4.34 to $4.37 from 11 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $4.67, with estimates from $4.51 to $4.82 from 11 analysts.

    What revenue do analysts expect from Merit Medical Systems next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $1.64B, with estimates from $1.64B to $1.64B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $1.74B, with estimates from $1.72B to $1.76B.

    How many analysts cover MMSI?

    12 analysts rate Merit Medical Systems stock, and 11 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.